Clinical trials: Relapsed or Plateau-Phase Multiple Myeloma
- Condition Relapsed or Plateau-Phase Multiple Myeloma
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Relapsed or Plateau-Phase Multiple Myeloma
Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab
The purpose of this study is to determine if denosumab is effective in the treatment of relapsed or plateau-phase multiple myeloma.
- Trial name
- NCT00259740
- Testing
- DENOSUMAB
- Volunteers
- 96 people
- Sponsor
- Amgen